Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
The Column Group

The Column Group

A venture capital firm in California that focuses on developing biotechnology companies.

The Column Group is a venture capital firm in California that focuses on developing biotechnology companies. Founded 2006 in San Francisco, California, United States by Adriana Tajonar and Peter Svennilson, it invests in early stage ventures, late stage ventures, private equity, seed, series B, series A, series C, and series E rounds. Its portfolio companies include Circle Pharma, Nurix, A2 Biotherapeutics, Plexium, and Tenaya Therapeutics. As of March 2020, The Column Group has made 67 investments. Their most recent investment was on March 17, 2020, when Circle Pharma raised $45M. The Column Group has had 13 exits, the most notable of which include PTC Therapeutics, Peloton Therapeutics, and NGM Biopharmaceuticals. The Column Group has raised three funds, their latest being Column Group IV.

Timeline

2006
Founded

Invested in

Associated investment funds

Patents

Funding Rounds Participated In

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

News

Title
Author
Date
Publisher
Description
Kate Goodwin
April 21, 2021
BioSpace
Investment funds continue springing up into life sciences companies across the globe. Here's where the money's being planted this week.
Kate Goodwin
April 20, 2021
BioSpace
Science-driven VC firm The Column Group set up its debut crossover fund with an oversubscribed $824 million to start.

References

Golden logo
By using this site, you agree to our Terms & Conditions.